2023 Annual Performance Forecast
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
2023 Annual Performance Forecast
Filed with SSE ·
2023 Annual Performance Forecast
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
View Attachment
6ix hasn’t read this filing yet.
Jiangsu gdk Biotechnology Co., Ltd. on 6ix
Earlier from Jiangsu gdk Biotechnology
- Announcement on Completing Cancellation of Wholly-owned Subsidiary
- Announcement on Release of Freeze over Some Funds in Special Accounts for Raised Funds
- Announcement on Freezing over Some Funds in Special Account for Raised Funds
- Announcement on Resignation and Appointment of Senior Management Members
- Announcement on Voluntary Disclosure of Obtaining Lot Release by Company's Quadrivalent Influenza Vaccine for 2023-2024 Influenza Season
Later from Jiangsu gdk Biotechnology
- Announcement on 2023 Annual Preliminary Earnings Estimate
- Announcement on Convening 2023 Annual Performance Meeting
- Announcement on Resolutions of 2023 Annual General Meeting
- Announcement on Resignation and Appointment of Senior Management Member
- Announcement on Adjustment of Products' Prices
Follow Jiangsu gdk Biotechnology into a list and get an email when it puts out news.
Follow Jiangsu gdk Biotechnology